AlphaYouDK
Insider selling
David Krempa sold Eton Pharmaceuticals, Inc. (ETON) stock
David Krempa, Chief Business Officer of Eton Pharmaceuticals, Inc. (ETON), sold 100,000 shares of ETON stock, per an SEC Form 4 filed May 27, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 22, 2026, 5 days before it was made public.
ETON has moved +69.7% since the trade date, from $32.59 to $55.31 (Sep 21, 2026 close).
- Traded
- May 22, 2026
- Disclosed
- May 27, 2026
- Filing delay
- 5 days
- Price since
- +69.7%
- Role
- Chief Business Officer
- Source
- SEC Form 4
More ETON insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.